Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re: Luoma
-
March 11, 2022
Fed. Circ. Flushes Drain Device Patent
The Federal Circuit backed a ruling Friday from the Patent Trial and Appeal Board that threw out a patent covering a device for unclogging drains, agreeing with the board that a similar device designed in 1906 already covered it.
-
December 01, 2021
Nobody Wants To Defend Ax Of Drain Device IP, Fed. Circ. Told
An inventor has asked the Federal Circuit to reverse an inter partes reexamination decision that invalidated his patent covering a device for unclogging drains — asserted in a decade-old New Jersey lawsuit — and that he says was "so weak that no one will appear to defend it."
-
March 04, 2020
USPTO Tells Full Fed. Circ. Arthrex Doesn't Apply To Reexams
The U.S. Patent and Trademark Office is urging the Federal Circuit to reconsider its decision ordering the agency to hold a new hearing in a patent reexamination in light of the Arthrex ruling, saying reexaminations involve different legal issues that do not require the same remedy.
-
January 21, 2020
Fed. Circ. Cites Arthrex In Shipping Patent Case Back To PTAB
Rebuffing the U.S. Patent and Trademark Office director, the Federal Circuit has ordered the agency to hold a new hearing in a patent reexamination in light of the Arthrex decision.